Form 4 for ORA ORMAT TECHNOLOGIES, INC.
Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-07 · accession 0001437749-25-034160 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-10 | 2025-11-07+ | ORA | Woelfel Jessica | GC, CCO, CS | M - OptEx | $71.15 | +2,889 | 4,433 | +187% | +$205.6K |
| DM | 2025-11-10 | 2025-11-07+ | ORA | Woelfel Jessica | GC, CCO, CS | S - Sale+OE | $114.11 | -1,089 | 3,433 | -24% | -$124.3K |
| DM | 2025-11-10 | 2025-11-07+ | ORA | Woelfel Jessica | GC, CCO, CS | D - Sale to Iss | $114.07 | -1,800 | 4,154 | -30% | -$205.3K |
| DM | 2025-11-10 | 2025-11-07+ | ORA | Woelfel Jessica | GC, CCO, CS | M - OptEx | $0.00 | -2,889 | 2,851 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | M | A | 1,889 | $71.15 | 5,322 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-07 | S | D | 368 | $112.36 | 3,433 | D | — | — | (F3) The price reported in column 4 is a weighted average price. These shares were executed and sold in multiple transactions at prices ranging from $112.35 to $112.39, inclusive. The reporting person undertakes to provide to Ormat Technologies, Inc. (the "Company"), any securityholder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range specified herein. |
| 3 | Common | Common Stock | 2025-11-07 | D | D | 632 | $112.36 | 3,801 | D | — | — | (F2) This represents the difference between the number of SARs exercised (1,000) and the number of shares issued as a result of the exercise (368). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($112.36) and the exercise price ($71.15). |
| 4 | Common | Common Stock | 2025-11-07 | M | A | 1,000 | $71.15 | 4,433 | D | — | — | |
| 5 | Common | Common Stock | 2025-11-10 | S | D | 721 | $115.00 | 3,433 | D | — | — | |
| 6 | Common | Common Stock | 2025-11-10 | D | D | 1,168 | $115.00 | 4,154 | D | — | — | (F6) This represents the difference between the number of SARs exercised (1,889) and the number of shares issued as a result of the exercise (721). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($115.00) and the exercise price ($71.15). |
| 7 | Derivative | Stock Appreciation Rights (SARs) | 2025-11-10 | M | D | 1,889 | $0.00 | 962 | D | $71.15 · 2024-03-01 to 2028-03-01 | 1,889 Common Stock | |
| 8 | Derivative | Stock Appreciation Rights (SARs) | 2025-11-07 | M | D | 1,000 | $0.00 | 2,851 | D | $71.15 · 2024-03-01 to 2028-03-01 | 1,000 Common Stock |